What question did this study set out to answer?

To determine whether active pharmacological treatment of hypertension reduces cardiovascular morbidity and mortality in elderly patients.

August 1, 1986Journal of Hypertension

STOP-Hypertension: Swedish Trial in Old Patients with Hypertension

View Full Paper

Ask AI

Bookmark

To determine whether active pharmacological treatment of hypertension reduces cardiovascular morbidity and mortality in elderly patients.
Randomized, double-blind, placebo-controlled clinical trial conducted in elderly hypertensive patients aged 70–84 years.
Patients received active antihypertensive therapy (beta-blockers and/or thiazide diuretics) or matching placebo.
Cardiovascular morbidity, stroke incidence, and total mortality were tracked as primary clinical endpoints.
Active antihypertensive treatment significantly reduces the risk of stroke and major cardiovascular complications compared to placebo.
Treatment provides a marked reduction in total cardiovascular mortality among older hypertensive individuals.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Randomized trial demonstrates reduced cardiovascular morbidity in elderly patients with hypertension, highlighting benefits of active blood pressure reduction.

Cite This Study

Hansson et al. (1986) studied this question.

synapsesocial.com/papers/6a91512c9ea92d4f71f077a2 https://doi.org/10.1097/00004872-198608000-00019

Topics

Hypertension management

View Full Paper

Ask AI

Bookmark

Implication

Randomized trial demonstrates reduced cardiovascular morbidity in elderly patients with hypertension, highlighting benefits of active blood pressure reduction.

STOP-Hypertension: Swedish Trial in Old Patients with Hypertension

Key Points

Discussion

Implication

Cite This Study

Topics

STOP-Hypertension: Swedish Trial in Old Patients with Hypertension

Key Points

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider